Givaudan | GIVN - Beneficio Bruto En Ventas





Beneficio Bruto En Ventas Cambio Fecha
Air Liquide EUR 8.65B 4.44B 2024-12
Akzo Nobel EUR 978M 42M 2026-03
Anheuser-Busch USD 9.58B 932M 2026-06
Arkema EUR 384.1M 70.9M 2026-03
Associated British Foods GBP 382.5M 8.73B 2024-12
BASF EUR 4.33B 181M 2026-06
Bayer EUR 6.33B 1.84B 2026-06
Beiersdorf EUR 1.54B 1.16B 2025-06
British American Tobacco GBP 5.09B 6.36B 2024-06
Covestro EUR 212M 276M 2025-12
Croda International GBP 366.7M 183.1M 2024-12
Danone EUR 6.82B 23M 2024-12
Diageo GBP 6.39B 950M 2025-12
Fresenius EUR 1.55B 16M 2026-06
Fresenius Medical Care EUR 1.31B 130.98M 2026-06
Givaudan CHF 1.55B 140M 2025-12
Heineken EUR 3.16B 276M 2024-12
International Flavors Fragrances USD 853M 165M 2026-06
Johnson Matthey GBP 480M 33M 2024-06
Kerry EUR 4.71B 656.3M 2022-12
Lonza CHF 1.29B 248M 2025-06
L'Oréal EUR 17.78B 1.82B 2026-06
Merck EUR 3.17B 101M 2026-06
Nestle CHF 19.99B 1.44B 2026-06
Pernod Ricard EUR 3.11B 371M 2025-12
Reckitt Benckiser GBP 4.25B 2.08B 2024-12
SGS CHF 762.5M 48.5M 2024-12
Sika AG CHF 3.02B 104.6M 2025-12
Solvay EUR 213M 53M 2026-06
Tate & Lyle GBP 902M 53M 2023-06
Umicore EUR 308.6M 10.45M 2024-12
Victrex GBP 68.3M 4M 2025-12